Amicus Therapeutics (FOLD) to Acquire Scioderm in ~$950M Deal
August 31, 2015 6:29 AM
Amicus Therapeutics (NASDAQ: FOLD) and Scioderm, Inc. a privately-held biopharmaceutical company focused on developing innovative therapies for treating diseases with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
